Micro RNA Market in United States, United Kingdom– Market Outlook, Unmet Needs, Market Assessment & Forecast (2023-2030)

MicroRNA Market – Report Overview

Pacific Business Consulting’s “MicroRNA Market in 10MM – Market Outlook, Unmet Needs, Market Assessment & Forecast (2023-2030)” report offers a comprehensive understanding of MicroRNA market, encompassing historical and projected market size data, along with market trends, market drivers, market barriers and unmet medical needs in the Ten Major Markets (10MM) of the United States, Germany, Spain, Italy, France, the United Kingdom, Japan, China, Australia, and India.

In 2022, the MicroRNA market exceeded a valuation of US$ 2.1 Billion and is set for substantial growth, with a projected Compound Annual Growth Rate (CAGR) surpassing 9.0% from 2023 to 2030. The market is anticipated to potentially reach beyond US$ 3.5 Billion by 2030.

The integration of MicroRNAs (miRNA) diagnostics into clinics has accelerated advancements in precision medicine for cancer treatment. MiRNAs, serving as noninvasive biomarkers in cancer, are particularly attractive due to their secretion by numerous cells, detectable in various body fluids. The significant demand for microRNA, driven by their roles in gene regulation and disease pathways, is a key factor propelling market growth.

The COVID-19 pandemic has further boosted microRNA research, contributing to vaccine development and understanding disease gene expressions. Studies indicate the potential use of miRNAs specific to the SARS-CoV-2 RNA genome for vaccine development. Additionally, certain miRNAs play a crucial role in combating COVID-19, with their levels decreasing in relation to a patient’s age or health conditions. This insight aids in comprehending the heightened vulnerability of individuals with comorbidities and the elderly to COVID-19. The surge in COVID-19 studies involving miRNA is expected to drive overall market growth, supported by research suggesting the use of an identified and validated SARS-CoV-2 miRNA signature for the differential diagnosis of COVID-19 from other infections with similar symptoms.

MiRNAs are increasingly recognized as robust biomarkers for human diseases, regulating gene expression post-transcriptionally. Their stability in serum and plasma encourages their use for diagnostic and prognostic biomarker applications. Circulating miRNAs within exosomes act as serum biomarkers, providing information on immunological status in healthy and diseased conditions. This potential application of circulating miRNAs as biomarkers for immunological conditions supports their role in overall market growth.

Partnerships and collaborations play a crucial role in driving the miRNA market, fostering innovation, leveraging expertise, and accelerating the development and commercialization of miRNA-based products. Notably, in 2023, Thermo Fisher Scientific, Inc. announced a collaboration agreement with Pfizer to expand local accessibility to NGS-based testing for breast and lung cancer patients in over 30 Latin American, African, Middle Eastern, and Asian countries where advanced genomic testing was previously limited or unavailable.

The global increase in the prevalence of diseases such as cancer, cardiovascular diseases, and neurological disorders, coupled with advancements in genomic technologies, are key factors propelling market growth. According to the American Cancer Society in 2022, the U.S. reported approximately 1.9 million new cancer cases, resulting in 609,360 cancer-related deaths.

Key players in the MicroRNA segment, including Merck KGaA, Takara Bio, Inc, LGC Limited, BioGenex, GeneCopoeia, Inc, New England Biolabs, Thermo Fisher Scientific, Inc., QIAGEN, Horizon Discovery Group plc, NanoString Technologies, Inc., are expected to play a pivotal role in shaping the future landscape of MicroRNA technologies through ongoing innovation.

Scope of Report

The report addresses critical subjects such as strategic competitor evaluation, market characterization, unmet needs, and the consequences of these elements for the MicroRNA market. It also delves into the analysis of present and prospective market competition within the global MicroRNA market.

Furthermore, the report offers an insightful examination of the primary industry drivers, constraints, and challenges. Each trend undergoes independent research to furnish qualitative analysis regarding its implications.

Reasons to Buy

• Develop your business strategies by gaining insights into the trends that shape and drive the MicroRNA market across the 10MM (Ten Major Markets).
• Increase revenue by comprehending key trends, innovative products and technologies, market segments, and companies poised to influence the future of the 10MM MicroRNA market.
• Craft effective sales and marketing strategies by thoroughly understanding the competitive landscape and analyzing the performance of various competitors.
• Identify emerging players with potentially robust product portfolios and devise strategic counter-strategies to gain a competitive advantage.
• Optimize your sales and marketing efforts by pinpointing market categories and segments that offer the greatest opportunities for consolidations, investments, and strategic partnerships.

1. Executive Summary: MicroRNA
   • Global Market Outlook: MicroRNA
2. Competitive Intelligence Analysis: MicroRNA
3. Therapeutic Sector SWOT
4. Technology Roadmap Analysis: MicroRNA
5. Market Background
   • Drivers
   • Restraints
   • Opportunity
   • Key Market Trends
   • Key Unmet Needs
6. Key Marketed Products Profile – Major Approved Products: MicroRNA
   • Product Profile
   • Safety and Efficacy
7. Regulatory Landscape
8. MicroRNA: Ten Major Market (10MM) – Market Analysis, By Assay Type
   • PCR-based
   • Next Generation Sequencing (NGS)
   • miRNA Assays
   • Immunoassays
9. MicroRNA: Ten Major Market (10MM) – Market Analysis, By Application
   • Academics & Research
   • Clinical Diagnostics
10. MicroRNA: Ten Major Market (10MM) – Market Analysis, By End User
    • Pharmaceutical & Biotechnology Companies
    • Diagnostic Companies
    • Academic & Research Institutes
11. MicroRNA: Ten Major Market (10MM) – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Assay Type
      • By Application
      • By End User
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Assay Type
      • By Application
      • By End User

12. S. MicroRNA – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Assay Type
      • By Application
      • By End User
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Assay Type
      • By Application
      • By End User

13. K. MicroRNA – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Assay Type
      • By Application
      • By End User
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Assay Type
      • By Application
      • By End User

14. Germany MicroRNA – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Assay Type
      • By Application
      • By End User
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Assay Type
      • By Application
      • By End User

15. France MicroRNA – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Assay Type
      • By Application
      • By End User
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Assay Type
      • By Application
      • By End User

16. Italy MicroRNA – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Assay Type
      • By Application
      • By End User
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Assay Type
      • By Application
      • By End User

17. Spain MicroRNA – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Assay Type
      • By Application
      • By End User
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Assay Type
      • By Application
      • By End User

18. Japan MicroRNA – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Assay Type
      • By Application
      • By End User
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Assay Type
      • By Application
      • By End User

19. China MicroRNA – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Assay Type
      • By Application
      • By End User
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Assay Type
      • By Application
      • By End User

20. Australia MicroRNA – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Assay Type
      • By Application
      • By End User
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Assay Type
      • By Application
      • By End User

21. India MicroRNA – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Assay Type
      • By Application
      • By End User
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Assay Type
      • By Application
      • By End User

22. Competitive Landscape
    • Company Overview
    • Product Portfolio
    • Key Financials
    • Sales Footprint

Note – All Major Company Profiles (Count up to 20) will be covered in the report

23. Assumptions and Acronyms Used
24. Research Methodology
    • Secondary Research
    • Primary Research
    • Data Triangulation
25. Geographic Scope
    • The U.S., The U.K., Germany, France, Italy, Spain, Japan, China, Australia, and India
26. Copyrights and Disclaimer